021-51111890
购物车（）
sales@molnova.cn
SB 206553
CAS No. 1197334-04-5
SB 206553 ( SB206553 )
产品货号. M10703 CAS No. 1197334-04-5
SB 206553 is a potent and selective 5-HT2B/5-HT2C receptor antagonist with pA2 of 8.89 for rat 5-HT2B, pKi of 7.92 for human 5-HT2C, displays >80-fold selectivity over other 5-HT receptor subtypes.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥8667 | 有现货 |
|
| 50MG | ￥17658 | 有现货 |
|
| 100MG | ￥22680 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称SB 206553
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述SB 206553 is a potent and selective 5-HT2B/5-HT2C receptor antagonist with pA2 of 8.89 for rat 5-HT2B, pKi of 7.92 for human 5-HT2C, displays >80-fold selectivity over other 5-HT receptor subtypes.
-
产品描述SB 206553 is a potent and selective 5-HT2B/5-HT2C receptor antagonist with pA2 of 8.89 for rat 5-HT2B, pKi of 7.92 for human 5-HT2C, displays >80-fold selectivity over other 5-HT receptor subtypes; exhibits anxiolytic-like properties both in vitro and in vivo.Anxiety Discontinued
-
同义词SB206553
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT Receptor
-
研究领域Neurological Disease
-
适应症Anxiety
化学信息
-
CAS Number1197334-04-5
-
分子量328.80
-
分子式C17H16N4O.HCl
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(N1C(C(CC1)=C2)=CC3=C2N(C)C=C3)NC4=CC=CN=C4.[H]Cl
-
化学全称3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']dipyrrole-1(2H)-carboxamide hydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Forbes IT, et al. J Med Chem. 1995 Jul 7;38(14):2524-30.
2. Upton N, et al. Eur J Pharmacol. 1998 Oct 16;359(1):33-40.
3. Kennett GA, et al. Br J Pharmacol. 1996 Feb;117(3):427-434.
4. Porras G, et al. Neuropsychopharmacology. 2002 Mar;26(3):311-24.
2. Upton N, et al. Eur J Pharmacol. 1998 Oct 16;359(1):33-40.
3. Kennett GA, et al. Br J Pharmacol. 1996 Feb;117(3):427-434.
4. Porras G, et al. Neuropsychopharmacology. 2002 Mar;26(3):311-24.
产品手册
关联产品
-
Urapidil hydrochlori...
Urapidil hydrochloride is an α1-adrenoceptor antagonist and 5-HT1A receptor agonist.
-
Vidofludimus
Vidofludimus (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
-
PF-05212377
PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease.
